Treatment of C3H/HeJ grafted mice with baricitinib [prevention]

ABSTRACT: The C3H/HeJ grafted model of alopecia areata was used to determine the efficacy of systemic baricitinib at preventing alopecia or treating established disease. The efficacy of topical baricitinib at treating established alopecia in the C3H/HeJ grafted model was also assessed. Microarrays were performed on skin RNA at week 0 and week 12 after starting treatment in all models. Baricitinib was administered in systemic form at the time of grafting. Skin samples were taken after 12 weeks.

ORGANISM(S): Mus musculus

SUBMITTER: Ali Jabbari 

PROVIDER: E-GEOD-61551 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress